About Transnetyx
Transnetyx is a Healthcare company based in Memphis (United States) founded in 2000, and was acquired by Thompson Street Capital Partners in March 2018. Automated genotyping services for murine cell lines are developed. The company has 150 employees. Transnetyx has completed 3 acquisitions, including A Tune, BrainBits and Laragen. Its website transnetyx.com draws about 89 thousand monthly visits. Transnetyx offers products and services including Automated Genotyping Services and Free Trial Genotyping. Its focus areas include Life Sciences, Genomics, Genomics Services and Full Service. Its legal entity is TRANSNETYX, INC. Its competitors include Rejuvenate Bio, Genewiz and 20n; 2 of its 3 listed competitors have raised funding.
Company details
Transnetyx was founded in 2000 and is based in Memphis, United States, operating in the biotechnology sector. Automated genotyping services are provided for murine cell lines used in research. Samples are clipped by researchers into custom well plates and orders are placed online. Upon receipt, an automated system is utilized to generate genotyping results, supporting scientific workflows in genetics and cell line analysis.
- Headquarters Memphis, United States
- Employees 150
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website transnetyx.com
- Social LinkedIn X Facebook Instagram
- Acquired by Thompson Street Capital Partners (Mar 2018)
- Legal Name Transnetyx, Inc
- Latest Funding Round$22.5M (USD), Debt – Conventional
May 2018
- InvestorsAbacus Finance
& 2 more
- Employee Count150
- Investments & AcquisitionsA Tune
& 2 more
- Acquired byThompson Street Capital Partners
(Mar 2018)
Products & Services of Transnetyx
Transnetyx offers a comprehensive portfolio of products and services, including Automated Genotyping Services and Free Trial Genotyping.
Delivers fast and accurate DNA genotyping for research samples.
Provides complimentary genotyping for up to 10 samples.
Funding Insights of Transnetyx
- Total Rounds 2
- Last Round Debt – Conventional — $22.5M
- Investors Count 2
All 2 funding rounds of Transnetyx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2018 | $22.5M | Debt – Conventional | – | – | |
| Apr 2015 | Debt – Conventional | – | – |
3 investors in total: 3 institutional.
Investors in Transnetyx
Transnetyx has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Abacus Finance, Peninsula Capital Partners and Thompson Street Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Abacus Finance is engaged in providing tailored credit solutions to lower-middle market companies. | abacusfinance.com | New York, United States | ||
Private equity investments are managed across multiple sectors. | peninsulafunds.com | Southfield, United States | ||
A private equity firm focused on middle-market business investments. | tscp.com | St. Louis, United States |
Investor details for Transnetyx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Transnetyx
49 people are tracked at Transnetyx (18 in leadership, 31 in team); the tracked headcount is 150.
| Name | Role | Group |
|---|---|---|
Kristin Uyl | Director Of Key Accounts | Leadership |
Todd Little | Executive Director | Leadership |
Bob Bean | Founder, President and CEO | Leadership |
Jessica Janeczek | Vice President Of Global Sales | Leadership |
Andy Keys | Chief Commercial Officer (cco) | Leadership |
Martine S. | Director Of Sales Asia Pacific | Leadership |
Joel Schwalbe | Chief Digital & Technology Leader | Leadership |
Mike Gahan | Vice President Of Operations | Leadership |
Karen Woelke | Chief People Officer | Leadership |
John Minnick | Vice President Of Technology Strategy & Innovation | Leadership |
Megan Hoppel | VP of Finance | Leadership |
Jeanie W. | Vice President System Quality & Development | Leadership |
Courtney Drissel | Director Of Commercial Sales | Leadership |
Carol Garrett | Executive Assistant To Chief Executive Officer | Leadership |
Candice W. | Director Of Solutions & Services At Transnetyx | Leadership |
Charles Hardy Jr. | Head Of Ux/product Design | Leadership |
Bill Tempone | Chief Financial Officer | Leadership |
Rick Hays | Director Of Infrastructure And Information Security | Leadership |
Callie Baker | Customer Solutions Specialist | Team |
Megan Grotts | Senior Key Account Specialist | Team |
29 more people are available in the full profile.
Complete people profiles for Transnetyx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Transnetyx
Transnetyx has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include A Tune, BrainBits and Laragen.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Genomic sequencing services are provided for academic and private sectors. | laragen.com | Culver, United States | 1995 | Aug 2023 | •••• | |
Laboratory animal management software solutions are provided. | a-tune.com | Darmstadt, Germany | 1998 | Feb 2022 | •••• | |
Developer of micro-surgically dissected, live brain tissues from rats and mice for pharmaceutical use | brainbitsllc.com | Springfield, United States | 1999 | Feb 2021 | •••• |
Complete acquisition details for Transnetyx
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Transnetyx
7 dated milestones of Transnetyx across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Transnetyx is founded.
- Funding First funding round.
- Exit Acquired by Thompson Street Capital Partners.
- Funding Latest funding round, Debt – Conventional, of $22.5M.
- Acquisition Acquires BrainBits.
- Acquisition Acquires A Tune.
- Acquisition Acquires Laragen.
Competitors of Transnetyx
Transnetyx has 3 listed competitors in our database, 2 of them funded. They include Rejuvenate Bio, Genewiz and 20n.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| genewiz.com | 1999 | South Plainfield, United States | 452 | Genomic services are provided for the life sciences industry. | ||
| 20n.com | 2013 | San Francisco, United States | $2.22M | Computational tools are developed to engineer microbes for synthetic biology. |
Detailed competitors of Transnetyx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Transnetyx
The website of Transnetyx (transnetyx.com) receives about 88.6K visits a month.
- Monthly visits88.6K
▲ 11.2% vs previous month
Websites whose visitors overlap most with Transnetyx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
silencinggenomes.org | silencinggenomes.org | 100% | – | ||
| clontech.com | 99% | View details | |||
| cell.com | 94% | 5M | #14,619 | View details | |
| biorxiv.org | 92% | 3M | #19,954 | View details | |
| jax.org | 91% | 474.6K | #112,332 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Transnetyx
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Transnetyx (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Transnetyx
Complete news archive for Transnetyx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Transnetyx
Transnetyx was founded in 2000 and raised its 1st funding round 15 years after it was founded.
Transnetyx is headquartered in Memphis, United States. It is registered at Memphis, Tennessee, United States.
Transnetyx has 150 employees.
Transnetyx was founded in 2000 and is based in Memphis, United States, operating in the biotechnology sector. Automated genotyping services are provided for murine cell lines used in research. Samples are clipped by researchers into custom well plates and orders are placed online. Upon receipt, an automated system is utilized to generate genotyping results, supporting scientific workflows in genetics and cell line analysis.
Transnetyx's top competitors include Genewiz, Rejuvenate Bio and 20n.
Transnetyx offers Automated Genotyping Services and Free Trial Genotyping.
Transnetyx has 3 investors. Key investors include Abacus Finance, Peninsula Capital Partners, and Thompson Street Capital Partners.
Transnetyx operates through Transnetyx, Inc.
Yes. Transnetyx was acquired by Thompson Street Capital Partners in March 2018.